All News

Special consideration for pain management in patients with cancer. 

It’s never too far into flu season to educate patients.

Two new reports quantify the problem that community pharmacists have experienced firsthand.

A UMass Memorial telehealth-based program connects patients with credentialed clinicians who can prescribe medication-assisted treatment for opioid use disorder. 

Maternal vitamin D levels may play a role in influencing the development of ADHD.

Solid recommendations can require detective work. 

Is there enough diversity in the industry?

Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.

Licensure, accreditation, and shared priorities rank high.

Tips for getting the best from your team. 

CMS proposed taking action to increase transparency in Medicare Part D plan sponsors’ pharmacy performance measures.

Pharmacists can play an integral role in managing patients with inflammatory bowel disease (IBD) through medication management. 

A new method to produce vaccines could result in longer-lasting, cheaper vaccines and eliminate the need for refrigeration. 

Millennials were least likely to receive the flu vaccine and were the least-informed about the risks of influenza.

Shingles is not contagious; however, the potential for exposing a person to another viral infection that leads to shingles is very real.

The latest in how consumers are reacting to the new coronavirus, how it’s impacting pharmacies, and response efforts.

The FDA is warning consumers to avoid using dietary supplements containing cesium salts due to potentially significant safety risks.

A new study shows that patients who initiated treatment with blood pressure or cholesterol medications were more likely to reduce activity and gain weight.

Genentech announced new 1-year data from the SUNFISH trial evaluating risdiplam in spinal muscular atrophy.

Fresenius Kabi’s glucagon emergency kit is a cost-effective alternative to branded kit products.

Efficient Laboratories, Inc. is voluntarily recalling 1 lot each of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAXliquid products due to microbial contamination.

An Ohio law allowing pharmacists to dispense naloxone without a prescription was linked to a significant increase in naloxone dispensing rates, especially in low-employment areas.

The FDA posted results of its NDMA lab analysis of metformin products in the United States.

A supplemental application for cannabidiol oral solution (Epidiolex, GW Pharmaceuticals and Greenwich Biosciences) has been submitted for the treatment of seizures associated with tuberous sclerosis complex.

Baricitinib (Olumiant, Eli Lilly and Incyte) demonstrated positive results in the BREEZE-AD5 study of patients with atopic dermatitis.

A Publix Pharmacy under construction at a hospital in Daytona Beach, Florida, will help Publix Super Markets continue its expansion into the hospital pharmacy realm.

Eli Lilly’s lasmiditan (Reyvow) C-V 50 mg and 100 mg for the acute treatment of migraine is now available for prescription.

The FDA is requesting that manufacturers of bacitracin for injection voluntarily withdraw their product.